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Dioxin Receptor Adjusts Liver 
Regeneration After Acute Toxic 
Injury and Protects Against Liver 
Carcinogenesis
Nuria Moreno-Marín1, Eva Barrasa1, Antonio Morales-Hernández2, Beroé Paniagua1, Gerardo 
Blanco-Fernández3, Jaime M. Merino1 & Pedro M. Fernández-Salguero1
The aryl hydrocarbon receptor (AhR) has roles in cell proliferation, differentiation and organ 
homeostasis, including the liver. AhR depletion induces undifferentiation and pluripotency in normal 
and transformed cells. Here, AhR-null mice (AhR−/−) were used to explore whether AhR controls liver 
regeneration and carcinogenesis by restricting the expansion of stem-like cells and the expression 
of pluripotency genes. Short-term CCl4 liver damage was earlier and more efficiently repaired in 
AhR−/− than in AhR+/+ mice. Stem-like CK14 + and TBX3 + and pluripotency-expressing OCT4 + and 
NANOG + cells expanded sooner in AhR−/− than in AhR+/+ regenerating livers. Stem-like side 
population cells (SP) isolated from AhR−/− livers had increased β-catenin (β-Cat) signaling with 
overexpression of Axin2, Dkk1 and Cyclin D1. Interestingly, β-Cat, Axin2 and Dkk1 also increased during 
regeneration but more notably in AhR-null livers. Liver carcinogenesis induced by diethylnitrosamine 
(DEN) produced large carcinomas in all AhR−/− mice but mostly premalignant adenomas in less than 
half of AhR+/+ mice. AhR-null tumoral tissue, but not their surrounding non-tumoral parenchyma, 
had nuclear β-Cat and Axin2 overexpression. OCT4 and NANOG were nevertheless similarly expressed 
in AhR+/+ and AhR−/− lesions. We suggest that AhR may serve to adjust liver repair and to block 
tumorigenesis by modulating stem-like cells and β-Cat signaling.
Although cell renewal is very scarce in most mammalian tissues under homeostatic conditions, a rapid regenera-
tive response can be observed in certain organs upon exposure to toxic or harmful molecules. Lung and liver are 
among those organs since they can reestablish normal tissue architecture and functionality from the activation of 
undifferentiated precursors after treatment with damaging chemicals1–3.
Liver regeneration can be experimentally induced by partial hepatectomy or toxic injury, the former exempli-
fied by two-third hepatic resection and the second by acute carbon tetrachloride (CCl4) treatment2–4. The mecha-
nisms and cell types involved differ between both processes. While partial hepatectomy predominantly activates 
the division of quiescent hepatocytes3, 4, the response to acute toxic damage appears to be associated to the prolif-
eration of hepatocytes and to a plausible increase in undifferentiated liver stem-like cells4–7. Hepatic CCl4 toxicity 
involves necrotic cell death and an acute inflammatory reaction caused by the infiltration of polymorphonuclear 
leukocytes and macrophages to the dead tissue2. Undifferentiated cells expressing pluripotency-inducing factors 
also appear to have a significant role in liver cancer progression and dissemination8–10. Despite some controversy 
about the phenotype of liver stem cells, certain molecular markers including cytokeratin 14 (CK14)11, 12 and 
TBX313 have been proposed to define early progenitor liver cells. Interestingly, a subpopulation of cells expressing 
Axin2 and TBX3 has been identified close to the central vein whose self-renewing potential is dependent on Wnt 
signals produced by the endothelium13. In addition, recent studies have identified pluripotency and reprogram-
ming factors OCT4, NANOG and SOX2 as relevant molecular intermediates able to sustain stem-like properties 
in the liver and the progression of hepatocellular carcinomas from hepatic cancer stem cells14–18.
The aryl hydrocarbon/dioxin receptor (AhR) interacts with signalling pathways controlling not only the 
cell response to toxic and carcinogenic compounds but also relevant physiological functions19, 20. Recent work 
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suggests that AhR may have a causal role in maintaining cell differentiation in the immune system21–24, gonads25, 
melanoma tumors26, 27 and skin epithelium28. AhR expression appears also relevant in embryonic stem cells29, 30, 
osteoblasts31, 32 and embryonic teratocarcinoma cells33. Notably, AhR deficiency exerts a profound impact in the 
hepatic system so that AhR-null mice have reduced liver size and portal fibrosis34–36 and a persistent intrahepatic 
porto-systemic shunt37, 38.
Previous studies have shown that AhR activation by its prototype carcinogenic ligand TCDD (2,3,7,8-tetrac
hlorodibenzo-p-dioxin) inhibits caudal fin and heart regeneration in zebrafish larvae, suggesting a link between 
AhR signalling and activation of embryonic-like cells early in development39. In mammals, few reports have 
shown that TCDD can partially impair liver regeneration in mice after two-third partial hepatectomy possibly by 
controlling the levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip140, 41.
In this work, we have used AhR wild type (AhR+/+) and AhR-null (AhR−/−) mice to investigate how AhR 
deficiency affects the activation of stem-like and pluripotent cells in the liver during regeneration after acute 
exposure to the hepatotoxin CCl4 and in hepatic tumors induced by the carcinogen diethylnitrosamine (DEN). 
We have found that AhR depletion improved liver regeneration and promoted the growth of large hepatocarci-
nomas likely by a mechanism involving increased proliferation and the activation of cells expressing stemness 
markers. These results could be of interest to develop non-toxic AhR antagonists to restore liver structure and 
function after toxic injury or after surgical intervention. Non-toxic AhR agonists could be also useful for inhibit-
ing liver tumor growth. Consequently, lack of AhR could be also considered a bad prognostic value in liver cancer.
Results
AhR deficiency improves liver regeneration after acute toxic injury. We have used the liver 
response to acute CCl4 toxicity as an experimental approach to analyze the role of AhR in tissue regeneration. A 
single dose of CCl4 induced severe organ damage with ample necrotic areas surrounding the central vein and per-
iportal areas of the hepatic parenchyma in both AhR+/+ and AhR−/− mice. (Fig. 1a). However, quantification 
of necrotic regions revealed that regeneration took place faster and more efficiently in AhR−/− mice since very 
few necrotic lesions remained at 72 h from treatment and their parenchyma was fully restored by 4 days. AhR+/+ 
mice, on the contrary, exhibited a delayed regenerative process that became significant at 72 h, persisting their 
Figure 1. AhR deficiency improves recovery from CCl4 induced necrosis. AhR+/+ and AhR−/− male 
mice were left untreated (UT) or treated with 0.7 ml/Kg CCl4 and liver regeneration determined at 24 h, 
48 h, 72 h, 4 days and 7 days. (a) Liver sections were processed and stained by histological analyses using 
hematoxylin-eosin (H&E). Necrotic areas were quantified blinded by 6 independent observers (right panel). 
(b) AhR expression was analyzed by immunofluorescence using a specific antibody. An Alexa 633-conjugated 
secondary antibody was used for detection. DAPI staining was used to label cell nuclei. (c) The expression 
of the AhR canonical target gene Cyp1a1 was determined by RT-qPCR in the regenerating liver using total 
liver RNA and the oligonucleotides indicated in Supplementary Table 1. Gene expression was normalized 
by Gapdh and represented as 2−ΔΔCt. Four to five AhR+/+ and AhR−/− mice were used at each time point 
and at least 3 technical replicates per mouse were performed. A NIKON TE2000U microscope was used 
for immunohistochemistry. An Olympus FV1000 confocal microscope and the FV10 software (Olympus) 
were used for immunofluorescence. Bars: panel (a) 100 μm, panel (b) 50 μm; inset 25 μm. Data are shown as 
mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, n.s. not statistically significant. Arroheads mark necrotic areas 
in the liver parenchyma (panel a) or AhR positive cells (panel b).
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hepatic lesions for at least 4 days (Fig. 1a). Nonetheless, regeneration was completed by 7 days from CCl4 admin-
istration in both genotypes. AhR expression transiently increased during the repair process in CCl4 exposed 
AhR+/+ mice, reaching a maximum at 72 h in cells located close to the central vein to decrease to very low levels 
at 4 days (Fig. 1b). AhR induced by the regenerative process was transcriptionally active as determined by the 
marked induction of its canonical target gene Cyp1a1, that reached maximum levels at 72 h (Fig. 1c). As expected, 
AhR expression or Cyp1a1 induction were undetectable in AhR−/− livers (Fig. 1b).
Liver regeneration after CCl4 treatment involved enhanced cell proliferation in AhR+/+ and AhR−/− mice, 
although the kinetic with time differed between both genotypes. Proliferating cell nuclear antigen (PCNA) expres-
sion rapidly increased in AhR−/− livers reaching maximum values at 24 to 36 h to gradually decrease at later time 
points (Fig. 2a). PCNA positive cells also accumulated in AhR+/+ livers although their kinetic was delayed until 
48 to 72 h from CCl4 exposure (Fig. 2a). Interestingly, AhR−/− but not AhR+/+ livers had a significant amount 
of cytosolic PCNA protein at early stages of regeneration, probably resulting for a nuclear to cytoplasmic shuttling 
process that takes place to protect from apoptosis and to sustain cell survival and resistance to toxic agents42, 43. 
Thus, the more efficient regeneration observed in AhR-null livers involved an earlier proliferative response.
AhR modulates the generation of cell types expressing stem-like and pluripotency markers 
after CCl4 induced toxicity. Liver regeneration after exposure to toxic chemicals such as CCl4 seems to pre-
dominantly involve the activation of stem-like cells expressing, among others, CK14, c-kit and Flt311, 12, 44 mark-
ers. Resident primary hepatocytes could also contribute to resolve necrotic tissue damage induced by CCl43, 45. 
AhR−/− livers had increased basal numbers of CK14-expressing cells as compared to AhR+/+ mice (Fig. 2b). 
Shortly after CCl4 treatment (e.g. 48 h), CK14 expression was maintained in AhR+/+ livers and moderately 
decreased in AhR−/− livers. At later times from 72 h to 4 days, CK14 decreased to very low levels in both gen-
otypes (Fig. 2b). T-box transcription factor TBX3 is considered an early marker of pericentral liver progenitor 
cells13. Untreated AhR−/− livers had detectable numbers of TBX3 positive cells that markedly increased at 48 and 
72 h after CCl4 treatment. Basal AhR+/+ livers did not show detectable TBX3 positivity and this cell type only 
became induced at 48 h following CCl4 administration (Fig. 3a). We have previously reported that AhR represses 
pluripotency factors OCT4 and NANOG in human embryonic teratocarcinoma cells33. OCT4 expressing cells 
Figure 2. AhR-null livers develop an early proliferative response to CCl4 treatment. AhR+/+ and AhR−/− 
male mice were left untreated (UT) or treated with 0.7 ml/Kg CCl4 and liver regeneration determined at 
24 h, 48 h, 72 h, 4 days and 7 days. (a) Liver sections were analyzed for the presence of PCNA positive cells 
by immunofluorescence. The time-dependent kinetic was quantified for each time point and the results 
are shown in the right panel. (b) The presence of cells expressing the stem-like marker CK14 was analyzed 
by immunofluorescence in liver sections using a specific antibody. An Alexa 633-conjugated secondary 
antibody was used for detection. DAPI staining was used to label cell nuclei. Quantification of the results 
is shown in the right panel. Four to five AhR+/+ and AhR−/− mice were used at each time point and 
at least 3 technical replicates per mouse were performed. A NIKON TE2000U microscope was used for 
immunohistochemistry. An Olympus FV1000 confocal microscope and the FV10 software (Olympus) were 
used for immunofluorescence. Bars: panel (a) 50 μm, panel (b) 100 μm; inset 25 μm. Data are shown as 
mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, n.s. not statistically significant. Arroheads mark CK14 positive 
cells (panel b).
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were significantly more abundant in basal AhR−/− liver parenchyma than in AhR+/+ livers (Fig. 3b). After CCl4 
treatment, OCT4 expression peaked from 24 to 48 h in AhR-null mice to then progressively decrease at 72 h and 
4 days (Fig. 3b). In AhR+/+ livers, OCT4 positive cells also increased during regeneration but with a delayed 
kinetic reaching its maximum at 72 h and decaying to initial levels at 4 days (Fig. 3b). Endogenous expression of 
NANOG was also higher in AhR−/− livers and became maximally induced at 48 h (Fig. 3c). Similarly to OCT4, 
NANOG positive cells were less abundant in naive AhR+/+ livers and they did not significantly accumulate until 
late regeneration at 4 days (Fig. 3c).
AhR−/− livers have increased number of side population cells and upregulation of the β-Cat 
pathway. We next used cell sorting to analyze the stem-like side population (SP) in untreated AhR+/+ and 
AhR−/− mouse livers. Complete livers from naive AhR+/+ and AhR−/− mice were processed, stained for the 
stem-like markers CD133+ , CD44+ and CD29+ and positive cells isolated and characterized (see the Methods). 
AhR deficient livers had a significant increase in SP cells with respect to wild type livers (Fig. 4a), which is consist-
ent with their enhanced content in cell populations expressing progenitor and pluripotency markers. Recent stud-
ies have associated the stem cell phenotype in the liver with the upregulation of the Wnt/β-Cat signaling pathway 
and the activation of pluripotency factors OCT4, NANOG, TBX3 and SOX246–48. We therefore decided to analyze 
the Wnt/β-Cat pathway in SP cells isolated from AhR+/+ and AhR−/− livers. mRNA expression of β-Cat and of 
its transcriptional partners Tcf4 and Lef1 was markedly increased in AhR−/− SP cells as compared to AhR+/+ 
SP cells (Fig. 4b). No significant differences were observed for the Wnt receptor Lrp6 between both genotypes 
(Fig. 4b). Consistently, the expression of the canonical Wnt/β-Cat target gene Axin2 was increased whereas that 
of Dickkopf-related protein 1 (Dkk1) was markedly repressed in AhR−/− SP cells (Fig. 4c). Additional Wnt/β-Cat 
Figure 3. Increased liver progenitors and upregulated pluripotency genes could contribute to liver regeneration 
in AhR−/− mice. AhR+/+ and AhR−/− male mice were left untreated (UT) or treated with 0.7 ml/Kg CCl4 
and liver regeneration determined at 24 h, 48 h, 72 h and 4 days. TBX3 (a), OCT4 (b) and NANOG (c) positive 
cells were detected by immunofluorescence in liver sections using specific antibodies. An Alexa 633-conjugated 
secondary antibody was used for detection. DAPI staining was used to label cell nuclei. Data for each marker 
were quantified and the results are shown in the right panels. Four to five AhR+/+ and AhR−/− mice were 
used at each time point and at least 3 technical replicates per mouse were performed. An Olympus FV1000 
confocal microscope and the FV10 software (Olympus) were used for immunofluorescence. Bar: 50 μm; inset 
25 μm. Data are shown as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, n.s. not statistically significant. 
Arroheads mark TBX3 positive (panel a), OCT4 positive (panel b) or NANOG positive (panel c) cells.
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target genes Cyclin D1, c-Jun and matrix metalloproteinase-2 (Mmp2) were also overexpressed in AhR−/− SP 
cells with respect to AhR+/+ SP cells (Fig. 4d). The analysis of liver sections revealed similar levels of β-Cat 
protein in untreated AhR+/+ and AhR−/− mice (Fig. 5a). However, early during regeneration (24 h), β-Cat 
significantly accumulated in the pericentral region of AhR−/− livers and such accumulation persisted for at least 
36 h, to then return to basal levels at 48 h (Fig. 5a). AhR+/+ livers, on the contrary, only showed moderate β-Cat 
localization to pericentral areas at 72 h from CCl4 treatment (Fig. 5a). Axin2 mRNA was overexpressed under 
basal conditions in AhR−/− livers and its levels decreased from 48 h in parallel with the reduction in β-Cat pro-
tein (Fig. 5b). In AhR+/+ livers, Axin2 mRNA also decreased at 48 h from CCl4 exposure to return to basal levels 
at later times (Fig. 5b). Basal Dkk1 mRNA expression was repressed in AhR−/− livers as compared to AhR+/+ 
livers, but transiently increased at 48 h from treatment. In AhR expressing livers, Dkk1 became steadily repressed 
along the regenerative process (Fig. 5c). Thus, β-Cat signaling was enhanced in stem-like SP liver cells and at early 
stages of liver regeneration in vivo.
AhR deficiency increases liver tumor progression by diethylnitrosamine (DEN). We next used 
DEN-induced liver tumors to investigate if tumors growing in AhR deficient mice have altered expression of 
AhR-regulated pluripotency genes and changes in β-Cat activation. Acute DEN treatment at young age (e.g. 4 
and 5 weeks after birth) did not affect survival of AhR+/+ mice during a 1 year period. However, it did signif-
icantly affect the viabilility of AhR−/− mice since close to 25% of the animals died between 4 and 12 months 
after treatment (Fig. 6a). Mice surviving 12 months after DEN treatment were killed and their tumors used for 
analyses. In agreement with a previous report49, AhR deficiency induced massive liver tumors larger than 1 cm3 in 
25% of the animals; tumors invaded more than three quarters of the liver in the remaining 75% of AhR−/− mice 
(Fig. 6b). Almost half of AhR+/+ mice did not develop any distinguishable liver tumor and only a small fraction 
had lesions invading large areas of the liver or with sizes over 1 cm3 (Fig. 6b). In fact, tumor growth significantly 
increased total liver weight in AhR-null but not in wild type mice (Fig. 6c). Macroscopic evaluation identified 
small lesions (Fig. 6d, upper left) with steatosis in most AhR+/+ mice despite some animals having larger size 
tumors (Fig. 6d, upper right). AhR−/− mice, on the contrary, developed tumors with marked multiplicity and 
extensive vascularization and lymphocyte infiltration (Fig. 6e, upper). Pathological examination revealed that 
even the larger AhR+/+ tumors were pre-malignant adenomas whereas a significant fraction of those present in 
AhR−/− mice progressed to malignant hepatocarcinomas (Fig. 6d,e).
Figure 4. AhR−/− livers have incrased levels of SP cells and upregulation of the Wnt/β-Cat signaling 
pathway. (a) Livers were obtained from AhR+/+ and AhR−/− mice and processed to isolate and quantify 
side population cells (SP) by cell sorting. SP + cells are expressed with respect to the total number of liver 
cells. (b) mRNA was purified from SP cells isolated from both genotypes and used to analyze by RT-qPCR the 
mRNA expression of β-Cat and of molecular intermediates of the Wnt/β-Cat pathway Lrp6, Tcf4 and Lef1. 
(c,d) mRNA expression of Wnt/β-Cat canonical target genes Axin2 and Dkk1 (c) and Cyclin D1, c-Jun and 
Mmp2 (d) was also analyzed by RT-qPCR. Oligonucleotides used are indicated in Supplementary Table 1. Gene 
expression was normalized by Gapdh and represented as 2−ΔΔCt. Four AhR+/+ and AhR−/− mice were used 
and 3 experimental replicates following SP isolation were analyzed. Data are shown as mean ± SD. *p < 0.05, 
**p < 0.01, ***p < 0.001, n.s. not statistically significant.
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Protein analysis of tumors growing in AhR+/+ mice revealed a marked downregulation of AhR expression in 
the tumor proper (T) as compared to surrounding non-tumoral tissue (NT) from the same livers. AhR was unde-
tectable in tumoral (T) and non-tumoral tissue (NT) of AhR−/− mice (Fig. 7a). Thus, liver tumor progression 
may be associated to AhR downregulation. β-Cat protein was barely detectable in non-tumoral tissue (NT) of 
AhR+/+ livers but highly expressed in surrounding non-tumoral tissue (NT) of AhR−/− livers (Fig. 7b, left pan-
els). β-Cat was moderately expressed in largest AhR+/+ tumors (T) (Fig. 7b, upper right) but highly expressed 
and with nuclear localization in most AhR−/− tumors (T) (Fig. 7b, lower right). Consistently, mRNA expression 
of the β-Cat target gene Axin2 was significantly higher in AhR−/− than in AhR+/+ liver tumors (Fig. 7c). We 
next used immunofluorescence to determine whether liver tumor growth involved changes in the expression of 
OCT4 and NANOG. We found that both OCT4 and NANOG were similarly expressed and with a comparable 
cellular distribution in AhR+/+ and AhR−/− liver tumors, with a more punctuate pattern in the case of NANOG 
(Fig. 7d,e).
Discussion
With the exception of the lung in mammals and the caudal fin in zebrafish, tissue regeneration is a rare event and 
mostly restricted to the liver. Mammalian liver can be induced to regenerate to its initial mass after exposure to 
necrotic inducing agents or after tissue loss caused by partial hepatectomy2, 3. Although some controversy exists, 
it is generally accepted that liver regeneration after partial hepatectomy is largely hepatocyte-dependent whereas 
regeneration in response to toxic compounds such as CCl4 relies in liver progenitor stem-like cells with some 
contribution from primary hepatocytes2–4. To date, little is known about the mechanisms and molecular inter-
mediates that initiate, limit and terminate liver regeneration. Previous work has shown that AhR activation by 
TCDD can block heart and caudal fin regeneration in zebrafish50, 51. In the mouse, TCDD inhibited liver regener-
ation after two-third partial hepatectomy possibly by blocking the cell cycle through a p21Cip1-dependent mech-
anism40, 41. A recent study has revealed that TCDD enhanced the toxic effects of CCl4 in mouse liver probably by 
increasing cytochrome P450-2E1 expression in an AhR-dependent manner52. Here, we have investigated liver 
regeneration after CCl4-induced damage and the liver response to the tumor inducing agent DEN in AhR-null 
background. The main conclusion from this work is that AhR deficiency improves liver regeneration after acute 
toxic damage but promotes hepatocarcinoma development likely by the expansion of stem-like cells and the 
upregulation of pluripotency-related factors including β-Cat. From a clinical point of view, this work indicates 
Figure 5. β-Cat signaling is activated during liver regeneration in an AhR-dependent manner. AhR+/+ 
and AhR−/− male mice were left untreated (UT) or treated with 0.7 ml/Kg CCl4 for the indicated times. 
(a) Livers were obtained, fixed in formalin, embedded in paraffin and processed for β-Cat detection by 
immunofluorescence. Quantification of the results is shown in the right panel. (b,c) mRNA expression of Axin2 
(b) and Dkk1 (c) was analyzed by RT-qPCR in liver samples from AhR+/+ and AhR−/− mice at the indicated 
times after CCl4 treatment. Oligonucleotides used are indicated in Supplementary Table 1. Gene expression 
was normalized by Gapdh and represented as 2−ΔΔCt. Four to five AhR+/+ and AhR−/− mice were used at 
each time point and at least 3 technical replicates per mouse were performed. Bar: 50 μm; inset 25 μm. Data are 
shown as mean ± SD. **p < 0.01, ***p < 0.001, n.s. not statistically significant. Arroheads mark β-Cat positive 
cells (panel a).
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that AhR deficiency could be beneficial to increase liver regeneration after toxic injury or tissue loss (e.g. from 
partial hepatectomy) but detrimental as a potential cause of liver carcinogenesis.
AhR depletion improved liver regeneration after CCl4-induced injury including a more efficient and complete 
repair of necrotic regions surrounding the central vein and periportal areas, despite AhR−/− mice having similar 
sensitivity to this toxic compound. The more competent regeneration observed in AhR−/− livers was probably 
the consequence of an earlier proliferative response reaching maximum values by 24–36 h after injury, whereas 
it took over 48 h in AhR+/+ livers, in agreement with previous data from transplanted wild type mice53, 54. 
Consistently with current hypotheses2, 3, the accelerated repair in AhR-lacking mice could be related to the acti-
vation of progenitor stem-like cells residing in the liver under basal conditions. Accordingly, cells expressing 
adult liver progenitor markers CK14 and TBX311–13 were more abundant in AhR−/− livers and, importantly, 
they expanded soon at the beginning of the regeneration process, closely following the kinetics of proliferation 
and repair. Pluripotency factors OCT433, 55, 56 and NANOG33, both regulated by AhR in human embryonic ter-
atocarcinoma cells, were also overexpressed basally and shortly after liver repair in AhR-null mice. These data 
suggest that, in absence of AhR, enlarged pools of liver cells with stem-like characteristics may trigger an earlier 
regenerative reaction ultimately resulting in a more efficient repair. Therefore, AhR could serve as a limiting factor 
controlling physiological regeneration in order to avoid liver overgrowth. Such possibility agrees with the fact that 
AhR becomes upregulated in wild type livers around the time window when repair was about to be completed.
Enhanced Wnt/β-Cat signaling has been involved in the proliferation of normal and transformed liver cells, 
at least in part due to the upregulation of a set of pluripotency factors including OCT4 and NANOG15–18, 48. 
Interestingly, stem-like side population cells isolated from AhR−/− liver under physiological conditions showed 
upregulation of canonical Wnt/β-Cat signaling, suggesting a link between overactivation of this pathway and 
induction of OCT4 and NANOG in residing pluripotent stem cells early during liver repair. In fact, β-Cat has 
been proposed as a novel regulator of NANOG to sustain liver pluripotency48. The implication of β-Cat signaling 
in AhR-dependent liver regeneration was also supported by additional observations: first, the marked increase 
Figure 6. Lack of AhR increases the response to DEN-induced liver tumors. AhR+/+ and AhR−/− male mice 
were treated with the carcinogen DEN twice at 4 and 5 weeks of age. (a) Kaplan-Meier survival curve for a 1 
year period since treatment. Surviving mice were killed at the end of the experiment. (b) Liver tumors were 
recovered from mice and classified in three ranges of sizes corresponding to <2 mm3, >1 cm3 and those of more 
than ¾ of the liver. (c) Livers from DEN-treated AhR+/+ and AhR−/− mice were weighted and the results 
represented as percentage with respect to the average liver weight of untreated wild type and AhR-null mice. 
(d) Representative mild lesion (left) and grown liver tumor (right) from DEN-treated AhR+/+ mice are shown. 
Hematoxylin-eosin stained sections from the corresponding tumors are shown below. Arrowheads indicate liver 
lesions in AhR+/+ livers. (e) Representative fully-grown liver carcinomas from DEN-treated AhR−/− mice. 
Hematoxylin-eosin stained sections from the corresponding tumors are shown below. A total of 30 AhR+/+ 
and 30 AhR−/− mice were used. A set of 10 control mice for each genotype were also analyzed. Data are shown 
as mean ± SD. **p < 0.01. Bar: 100 μm.
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in β-Cat levels shortly after damage in AhR−/− mice but not in AhR+/+ mice; second, Axin2 was upregulated 
while Dkk1 was repressed in basal AhR−/− livers, supporting the existence of an endogenous regulatory path-
way; third, Dkk1 was induced in AhR-null livers once regeneration reached its maximum, which suggested a 
mechanism to attenuate the process since Dkk1 can inhibit β-Cat signaling57. Thus, AhR and β-Cat may be inter-
connected in a regulatory network controlling the generation of stem-like and pluripotent cells needed for liver 
regeneration. This hypothesis is supported by the fact that AhR activation alters Wnt/β-Cat signaling impairing 
tissue regeneration in zebrafish39, 58 and the formation of the urogenital sinus during prostate development59.
Figure 7. β-Cat is overactivated in AhR−/− liver tumors but OCT4 and NANOG are not significantly altered. 
AhR+/+ and AhR−/− male mice were treated with the carcinogen DEN twice at 4 and 5 weeks of age. (a) 
AhR protein expression was determined by immunoblotting in the tumor proper (T) and in surrounding non-
tumoral tissue (NT) from AhR+/+ and AhR−/− mice. β-Actin was used to normalize protein levels. AhR+/+ 
and AhR−/− samples correspond to non-adjacent lanes from the same blot. (b) β-Cat protein was analyzed 
by immunofluorescence in AhR+/+ and AhR−/− tumoral tissue (T) and in surrounding non-tumoral stroma 
(NT). (c) Axin2 mRNA levels were quantified by RT-qPCR in tumors obtained from livers of both genotypes. 
(d,e) Protein expression of OCT4 and NANOG were analyzed by immunofluorescence in AhR+/+ and 
AhR−/− liver tumors. Oligonucleotides used are indicated in Supplementary Table 1. Gene expression was 
normalized by Gapdh and represented as 2−ΔΔCt. Four biological replicates and 3 experimental replicates per 
mouse were analyzed. Bar: 50 μm; inset 25 μm. Data are shown as mean ± SD. *p < 0.05.
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In agreement with a previous study using a different AhR-null mice line49, AhR deficiency strongly increases 
the susceptibility to hepatocarcinogenesis eventually reducing survival in a significant fraction of mice. AhR−/− 
mice developed markedly large tumors, with increased multiplicity and vascularization and with complete pen-
etrance. AhR expression affected malignancy since liver carcinomas could be recovered from AhR−/− mice 
whereas adenomas were predominant in AhR+/+ mice. Notably, the causal role of AhR in liver tumorigenesis 
gains additional support from the fact that, in AhR+/+ tumors, it was strongly repressed in the tumor proper 
but not in the surrounding non-tumoral parenchyma. Although more work is needed to clarify this differen-
tial pattern of expression, it agrees with our previous observations describing cell-autonomous and stromal 
dependent functions of AhR in melanoma primary tumorigenesis and metastasis26. Similarly to that found for 
CCl4-induced injury, β-Cat expression and activation were also increased in AhR−/− tumors, again suggesting 
the existence of a β-Cat/AhR signaling network limiting progression of liver carcinogenesis. Interestingly, OCT4 
and NANOG expression did not significantly differ between AhR+/+ adenomas and AhR−/− carcinomas, a 
result that probably reflects a differential function of both genes in regeneration after acute toxicity with respect 
to liver carcinogenesis.
In summary, physiological control of AhR expression may be required to adjust a proportional proliferative 
response to repair necrotic damage in the liver caused by toxic chemicals. As AhR has relevant roles in controlling 
differentiation and pluripotency, and since β-Cat signaling promotes liver regeneration and is associated to the 
activation of pluripotency factors, it is reasonable to assume that a signaling network involving AhR and β-Cat 
could control the timing and the intensity of liver regeneration to restore tissue architecture and to avoid over-
growth. A similar network could also limit liver carcinogenesis in presence of AhR by restricting tumor growth 
and malignant progression. One relevant question that remains to be investigated is to what extent the effects 
reported here depend on the expansion of liver stem-like cells, on the absence of AhR in those cells or on both 
phenomena. The first possibility is supported by recent observations from our laboratory showing that AhR 
deficiency also improves lung regeneration after naphthalene-induced damage through an increase in the pool of 
basal and Clara stem-like cells (Hernández-Morales, unpublished observations), and that AhR-null testes have 
increased levels of early progenitor cells25. The second would imply that AhR deprivation triggers cell autono-
mous effects leading to undifferentiation and stemness. Indeed, AhR deficiency differentially affects melanoma 
primary tumorigenesis and metastasis depending on whether it is depleted in the tumor cell or in the stroma26, 27. 
Further, AhR knockdown enhances the undifferentiated phenotype of human embryonic teratocarcinoma cells 
by upregulating pluripotency genes OCT4 and NANOG33. It appears likely that AhR not only modulates stem cell 
function but also the expansion of undifferentiated cell populations. Further work will provide important insights 
into these novel roles of AhR.
Methods
Mice and treatments. AhR+/+ and AhR−/− mice were generated by gene targeting as previously 
described35. For liver regeneration experiments, male mice were used since the hormonal status of female rodents 
significantly affects the response to hepatotoxins60–62. Thus, four to five AhR+/+ and AhR−/− male mice for 
each time point at 12 to 14 weeks of age were treated with a single i.p. dose of 0.7 ml/Kg of pure CCl4 solution 
(Panreac 131245.1611) dissolved in sunflower oil; the same number of control mice received an equal volume of 
solvent. Mice were sacrificed 24 h, 48 h, 72 h, 4 days and 7 days after treatment and livers collected and processed 
for analysis. For liver tumor formation, 30 AhR+/+ and 30 AhR−/− male mice were injected twice at 4 and 5 
weeks of age i.p. with 15 mg/Kg body weight diethylnitrosamine (DEN) (Sigma N0258) dissolved in sunflower 
oil. A set of 10 AhR+/+ and 10 AhR−/− control mice received the same volume of sunflower oil and they were 
followed during the duration of the experiment. All work involving mice has been performed in accordance with 
the National and European legislation (Spanish Royal Decree RD53/2013 and EU Directive 86/609/CEE as mod-
ified by 2003/65/CE, respectively) for the protection of animals used for research. Experimental protocols using 
mice were approved by the Bioethics Committee for Animal Experimentation of the University of Extremadura 
(Registry 109/2014) and by the Junta de Extremadura (EXP-20160506-1). Mice had free access to water and 
rodent chow.
Antibodies and reagents. The following antibodies were used: anti-AhR (Immunostep EB11767 1:50), 
anti CK14 (COVANCE AF64 1:100), anti-OCT4 (Santa Cruz Biotechnology sc-5279, 1:200), anti-NANOG 
(Novus Biologicals NBP2-13177SS 1:50), anti-PCNA (Biolegend, 307902 1:50), anti-TBX3 (ABIN 1714884 1:50), 
anti-β-Cat (Becton-Dickinson 610153 1:200).
Hematoxylin/eosin staining of liver sections. Liver tissues were fixed overnight at room temperature 
in buffered formalin and included in paraffin. Sections were prepared at 3 μm, deparaffinated in xylol and gradu-
ally re-hydrated to phosphate buffered saline (PBS). Tissues were incubated for 3 min with hematoxylin, washed 
with tap water and stained with eosin for 1 min. After a final washing step, sections were de-hydrated, mounted 
and observed in a NIKON TE2000U microscope equipped with 4× (0.10 numeric aperture), 10× (0.25 numeric 
aperture) and 20× (0.40 numeric aperture) objectives.
Immunohistochemistry. Paraffin-embedded livers were sectioned at 3 μm, deparaffinated and re-hydrated 
to PBS. Sections were incubated for 45 min in PBS containing 0.25% Triton X-100 (PBS-T) and 0.3% H2O2 to 
block endogenous peroxidase activity. Following washing in PBS-T, unspecific binding was blocked by incu-
bation in PBS-T solution containing 2 mg/ml gelatin (PBS-T-G) and 0.1 M lysine. A primary antibody against 
the proliferating cell nuclear antigen (PCNA) was added for 16–18 h and, after washing in PBS-T-G, sections 
were incubated for 1 h at room temperature with the corresponding biotin-conjugated secondary antibody. After 
a final washing step in PBS-T-G, the streptavidin-peroxidase complex was added and the presence of PCNA 
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revealed with diaminobenzidine (DAB). Nuclei were then counterstained with Harris hematoxylin and sections 
de-hydrated and mounted with Eukitt (Kindler GmBH). A NIKON TE2000U microscope equipped with 4× 
(0.10 numeric aperture), 10× (0.25 numeric aperture) and 20× (0.40 numeric aperture) objectives was used for 
microscopic observation.
Immunofluorescence. Liver sections (3 μm) were initially processed as indicated above but omitting the 
blocking step. Unspecific epitopes were blocked by 1 h incubation at room temperature in TBS-T containing 0.2% 
gelatin and 3% BSA. Sections were incubated overnight at 4 °C with the corresponding primary antibodies diluted 
in PBS-T containing 0.2% gelatin, washed in the same gelatin solution and incubated for 1 h at room temperature 
with Alexa-488 or Alexa-633- labeled secondary antibodies. After washing the excess of secondary antibody, 
sections were dehydrated, mounted on Mowiol and visualized using an Olympus FV1000 confocal microscope 
(Olympus). Objectives used were: 10× (0.40 numeric aperture) and 20× (0.70 numeric aperture). Fluorescence 
analysis was done using the FV10 software (Olympus). DAPI was used to stain cell nuclei.
Reverse transcription and real-time PCR. Total RNA was purified from liver tissues at different times 
after CCl4 or DEN treatment. Tissues were grinded in liquid nitrogen, extracted using a Trizol reagent (Ambion)/ 
chloroform solution, centrifuged and the supernatants precipitated with isopropanol and centrifuged again at 
15000 g for 30 min at 4 °C. Pellets were dissolved in DEPC-treated water and the resulting solution further purified 
with the High Pure RNA Isolation Kit (Roche). Reverse transcription was done using random priming and the 
iScript Reverse Transcription Super Mix (Bio-Rad). Real-time PCR (qPCR) was performed using SYBR® Select 
Master Mix (Life Technologies) in a Step One Thermal Cycler (Applied Biosystems) as indicated25, 33. Gapdh was 
used to normalize target gene expression (ΔCt) and 2−ΔΔCt to calculate changes in mRNA levels with respect to 
untreated conditions. Primer sequences used are indicated in Supplementary Table 1.
SDS-PAGE and immunoblotting. SDS-PAGE and immunoblotting were performed using total protein 
extracts essentially as described25. Briefly, AhR+/+ and AhR−/− liver tumors and surrounding non-tumoral 
tissue were minced, homogenized in ice-cold lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% Nonidet 
P-40, 1 mM phenyl-methyl sulfonyl fluoride, 1 mM NaF, 1 mM sodium orthovanadate, 1 mM DTT, 10 mM 
β-glycerophosphate and 4 μg/μl Complete protease inhibitor cocktail) and centrifuged at 15000 g for 30 min at 
4 °C. Protein concentration was quantified in the supernatants using the Coomassie Plus protein assay reagent 
(Pierce) and bovine serum albumin as standard. Aliquots of 20-30 μg total protein were electrophoresed in 8% 
SDS-PAGE gels which were transferred to nitrocellulose membranes by electroblotting. Membranes were blocked 
in TBS-T (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.2% Tween-20) containing 5% non-fat milk. Blots were incu-
bated with a primary antibody against AhR and with the corresponding secondary antibody, washed in TBS-T 
and revealed using the Super-signal luminol substrate (Pierce) in a ChemiDoc XRS + equipment (Bio-Rad).
Side population (SP) isolation by cell sorting. The side population (SP) containing stem-like cells was 
isolated from AhR+/+ and AhR−/− livers essentially as described with some modifications63. In brief, livers 
were finely minced in PBS and rotated for 30 min at 37 °C in digestion solution (PBS containing 0.5 U/ml Dispase 
and 60 U/ml collagenase (Invitrogen)). Once digested, tissues were homogenized by passing through a 21-gauge 
syringe, filtered by a 0.40 μm mesh and centrifuged at 300 g for 5 min. Pellets were then resuspended in sorting 
medium (PBS containing 10% FBS) prior to use. To isolate SP cells, complete cellular pools obtained from each 
liver were stained for 90 min at 37 °C with a solution containing 5 μg/ml Hoechst 33342 (Sigma Aldrich). Cells 
were then centrifuged and resuspended in HEPES-HBSS buffer and incubated with 50 μM Fumitremorgin C 
(Sigma Aldrich) to inhibit the ABCG2 extrusion pump. Propidium iodide at a concentration of 10 nM was used to 
discriminate dead cells from the purification. Cells staining positive for the undifferentiation markers CD133 + , 
CD44 + and CD29 + were considered representative of the SP population. A MoFlo Astrium EQ flow cytometer 
(Beckman Coulter) was used.
Statistical analyses. Quantitative data are shown as mean ± SD. Comparisons between experimental 
conditions was done using GraphPad Prism 6.0 software (GraphPad). The student´s t test was used to ana-
lyze differences between two experimental groups and ANOVA for the analyses of three or more groups. The 
Mann-Whitney non-parametric statistical method was used to compare rank variations between independent 
groups.
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